The Future of Migraine Care…

                Is Coming

                    Stay in Touch

Patients want a better, easier option for migraine care.

So do we.

Relaspen is being developed to put the power of a better, faster migraine treatment, with no harsh side effects, into the hands of the patients who need it.  Relaspen is being developed as a self-administered intra-nasal treatment that delivers a local anesthetic directly to the SPG (Sphenopalatine Ganglion) nerve, located in the posterior nasal cavity.   By blocking, or “relaxing” this nerve, patients can stop an acute migraine anytime, anywhere, in as little as 15 minutes.

How Relaspen is Different

Relaspen is the first medical device designed to allow patients to easily and safely self-administer an SPG block to treat an acute migraine.  There are three other SPG block catheter devices currently FDA cleared and available on the market, but none of them are designed for patient self-administration.  Currently, the SPG block procedure is only performed in physician offices and hospitals.  Relaspen aims to allow patients to have access to this revolutionary migraine treatment with the push of a button.

What’s Next for Relaspen

Relaspen is being developed by Migraine Solutions, LLC, and is currently patent pending.  Our pathway to market entails product research and development to maximize efficacy and ease of use, followed by clinical trials and submission for FDA approval.

We are currently in the prototype phase. Interested in learning more or partnering with us? Contact us at

Migraine is the 6th most disabling disease in the world, according to the WHO.  There are 39 million migraine sufferers in the US and 1 billion worldwide.  Despite the wide array of treatment possibilities, less than one third of migraine sufferers report being satisfied with their current headache treatment.  

The Relaspen Difference

Migraine Treatment Developed with the Patient in Mind

Relaspen is unique because it will be the only device designed and FDA approved for primary use by patients instead of physicians. Because SPG blocks work best as abortive treatment, they need to be done as soon as possible after the onset of a migraine. Relaspen will have a broad appeal to the migraine community because it can be used frequently by chronic migraine sufferers, or it can be kept as a “just in case” treatment by those who only experience intermittent migraines. Its low side effect profile makes it preferable for those who do not tolerate other medications (a common complaint from migraine sufferers). For those who have benefited from physician administered SPG blocks in the past, Relaspen will represent a significant savings in both money and time compared to current SPG block options.

Migraine Solutions, LLC

Jason Cook, MD is the Founder and CEO of Migraine Solutions, LLC. Dr. Cook graduated magna cum laude from the University of the South in Sewanee, Tennessee. He received his medical degree from The University of Alabama School of Medicine, and went on to complete his residency with the MAHEC Family Medicine Program in Asheville, NC. He spent four years serving underserved rural populations of North Carolina as a member of the National Health Service Corps, then began his current practice with The Family Health Centers in 2014. In 2015 he founded The Family Health Centers Headache Clinic, where he provides both primary care and specialty headache care for thousands of patients every year. He is a Clinical Instructor of Family Medicine for the University of North Carolina School of Medicine where he lectures on advanced headache management to medical students and residents. He founded Migraine Solutions, LLC in 2017 to pursue development of a self administered SPG block device to help migraine patients worldwide.

Industry Insights

For many people that have migraines, their headaches begin in adolescence and adulthood. Their recurrence can be frequent to unpredictably erratic. There is a wide range of experiences from annoyance to incapacitation for extended periods. Some people are unable to function in their lives during migraine onsets, which may last up to several days.

For several decades, acute migraine sufferers could be prescribed opioids by primary caregivers or emergency personnel. With our better understanding of the opioid crisis, we better understand the risk of dependence and are trying to move away from reliance upon addictive treatments. Relaspen represents an effective, quick-acting, non-narcotic treatment for migraine sufferers.

There are a lot of migraine treatments out there, but for some patients the available treatments don’t help. Some medications are expensive, unpredictable, or simply don’t work. The SPG block works for a majority of patients by eliminating or dramatically decreasing the severity of migraines. Relaspen can get patients back to work or their activities in as little as 15 minutes. Blake Fagan, MD

Assistant Professor of Family Medicine, University of North Carolina School of Medicine

Many patients struggle with migraines for decades before seeking treatments. Patients treated with some traditional medications may feel like zombies, can’t drive, and can’t work. Often their physicians won’t suggest alternate treatments and patients will remain on heavy medication despite these side effects. Dr. Cook is the exception. He strives to offer patients a way to manage migraine symptoms while using less medication. Stopping migraines at the onset using Relaspen can be a key to breaking the migraine cycle and returning patients to work, to relationships, to parenting, and to life. Nicole Lindsey, DC

Founder, Back in Balance Chiropractic and Physical Therapy Center

Migraine Clinic Testimonials

Dr. Cook is one of the pioneers of self-administered SPG Block treatment for patients with chronic migraine. His patients’ positive experiences with this advancement in care have been the driving force in the creation of Relaspen, in order to bring the same relief that his patients have experienced to migraine sufferers all over the world. Here’s what some of his patients are saying.

I tried many types of treatments that didn’t help. I was having three or four migraines a week. I work long hours and am raising a toddler. I first tried a “cocktail” of medicines, but was limited by my insurance, which only allowed nine pills per month. I needed about nine pills per week.

I no longer feel overly medicated. My previous meds were tearing my stomach up, but now I can tell a huge difference. I’m down to two migraines a month. I was going to the doctor once or twice a month. Now, I haven’t been to the doctor in five months!

Tara G.

Migraine Patient

I tried Botox treatment twice, but it didn’t work, although it was very expensive. I am 67 years old and have migraines on my right side that affect my right eye and cause nausea. It’s really nice to know that I can make plans with people! In fact, I’m actually getting to go on vacation again without having to worry about headaches.

Rosa G.

Migraine Patient

It’s wonderful to be able to treat myself at home when I’m in severe pain. In 15 to 20 minutes, I’m back on my feet.

Emily A.

Migraine Patient

Just knowing that it’s there, reduces my anxiety.

Larry L.

Migraine Patient